SIRT1 and gastric cancer: We demonstrate that SIRT1 knockdown using siSIRT1 or inhibition of SIRT1 activity by EX527 treatment significantly reduces the expression of Vimentin, MMP-2 and MMP-9, and increases E-cadherin expression in the GC cells.